<DOC>
	<DOC>NCT02080715</DOC>
	<brief_summary>In this study, pharmacologic effects of COMT inhibition during sleep deprivation in healthy subjects in dependence of their Val158Met genotype of COMT are studied. Potential effects are identified by measurement of vigilance and cognitive performance as well as EEG measurements during wake and sleep. - Trial with medicinal product</brief_summary>
	<brief_title>Role of the Catechol-O-methyltransferase (COMT) in the Physiological Regulation of Vigilance</brief_title>
	<detailed_description />
	<mesh_term>Tolcapone</mesh_term>
	<criteria>Inclusion criteria: Healthy male subjects Age: 2030 years written informed consent right handed non smoker Exclusion criteria: sleep disturbances irregular sleepwake rhythm travelling with timeshift liver diseases (ALT: &gt; 82 U/l; AST: &gt; 76 U/l) diseases of the nervous system acute internal medicine diseases medication or drug abuse intake of more than 3 caffeinecontaining drinks intake of more than 5 alcoholic drinks per week heart pacemaker or implanted medical devices BodyMassIndex (BMI): 20&lt; BMI &gt;26</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Sleep-wake</keyword>
	<keyword>regulation</keyword>
	<keyword>volunteers</keyword>
</DOC>